BioCentury | Apr 15, 2013
Company News

Houghten deal

...totaling $750,000 to be paid on the third, fourth and fifth anniversaries of the transaction. Houghten Pharmaceuticals Inc....
BioCentury | Jun 18, 2001
Strategy

Reinventing chemistry

...branch out has not protected everyone. Thus Trega Biosciences Inc . (San Diego, Calif., formerly Houghten Pharmaceuticals Inc....
BioCentury | Apr 21, 1997
Company News

Houghten drug discovery news

...Biosciences Inc . on May 1. Its common shares will trade under the symbol "TRGA." Houghten Pharmaceuticals Inc....
BioCentury | Jan 20, 1997
Company News

Houghten other research news

...receptor and other MC receptors, reduces body weight, blood glucose, and insulin levels in animals. Houghten Pharmaceuticals Inc....
BioCentury | Jan 13, 1997
Company News

Houghten, Chugai deal

...of interest, the company will develop and commercialize any discoveries and pay royalties to Chugai. Houghten Pharmaceuticals Inc....
BioCentury | Dec 9, 1996
Clinical News

HP 228 cytokine regulator data

...doses were tested, given twice a day for 14 days in the double-blind, placebo-controlled study. Houghten Pharmaceuticals Inc....
BioCentury | Nov 18, 1996
Company News

Houghten deal

...will resign as HPIP's chief technical officer, but will remain on HPIP's board.(HPIP earnings, B13.) Houghten Pharmaceuticals Inc....
BioCentury | Oct 14, 1996
Company News

Houghten drug discovery news

...and withheld certain considerations from Dickman and Thompson. HPIP said the charges are without merit. Houghten Pharmaceuticals Inc....
BioCentury | Sep 30, 1996
Company News

Magainin, Houghten deal

...representing the fair value of the issued shares. Magainin Pharmaceuticals Inc. (MAGN), Plymouth Meeting, Penn. Houghten Pharmaceuticals Inc....
BioCentury | Sep 23, 1996
Clinical News

Houghten regulatory update

...San Diego, Calif.). HPIP has licensed the technology for its internal and collaborative chemistry program. Houghten Pharmaceuticals Inc....
Items per page:
1 - 10 of 30
BioCentury | Apr 15, 2013
Company News

Houghten deal

...totaling $750,000 to be paid on the third, fourth and fifth anniversaries of the transaction. Houghten Pharmaceuticals Inc....
BioCentury | Jun 18, 2001
Strategy

Reinventing chemistry

...branch out has not protected everyone. Thus Trega Biosciences Inc . (San Diego, Calif., formerly Houghten Pharmaceuticals Inc....
BioCentury | Apr 21, 1997
Company News

Houghten drug discovery news

...Biosciences Inc . on May 1. Its common shares will trade under the symbol "TRGA." Houghten Pharmaceuticals Inc....
BioCentury | Jan 20, 1997
Company News

Houghten other research news

...receptor and other MC receptors, reduces body weight, blood glucose, and insulin levels in animals. Houghten Pharmaceuticals Inc....
BioCentury | Jan 13, 1997
Company News

Houghten, Chugai deal

...of interest, the company will develop and commercialize any discoveries and pay royalties to Chugai. Houghten Pharmaceuticals Inc....
BioCentury | Dec 9, 1996
Clinical News

HP 228 cytokine regulator data

...doses were tested, given twice a day for 14 days in the double-blind, placebo-controlled study. Houghten Pharmaceuticals Inc....
BioCentury | Nov 18, 1996
Company News

Houghten deal

...will resign as HPIP's chief technical officer, but will remain on HPIP's board.(HPIP earnings, B13.) Houghten Pharmaceuticals Inc....
BioCentury | Oct 14, 1996
Company News

Houghten drug discovery news

...and withheld certain considerations from Dickman and Thompson. HPIP said the charges are without merit. Houghten Pharmaceuticals Inc....
BioCentury | Sep 30, 1996
Company News

Magainin, Houghten deal

...representing the fair value of the issued shares. Magainin Pharmaceuticals Inc. (MAGN), Plymouth Meeting, Penn. Houghten Pharmaceuticals Inc....
BioCentury | Sep 23, 1996
Clinical News

Houghten regulatory update

...San Diego, Calif.). HPIP has licensed the technology for its internal and collaborative chemistry program. Houghten Pharmaceuticals Inc....
Items per page:
1 - 10 of 30